Clinical Trials Directory

Trials / Terminated

TerminatedNCT03869749

The Moving 2 Mindful (M2M) Study: Mindfulness Group + Ecological Momentary Intervention

Decreasing Stress and Anxiety in Adolescents From High-Conflict Homes: Testing a Mindfulness Group + Ecological Momentary Intervention

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Colorado State University · Academic / Other
Sex
All
Age
14 Years – 18 Years
Healthy volunteers
Accepted

Summary

This study will evaluate the feasibility and acceptability of Learning to BREATHE (a mindfulness intervention for adolescents) plus an ecological momentary intervention (Learning to Breathe Plus), and will examine the extent to which mindfulness reduces dysregulated stress physiology, perceived stress, and anxiety in adolescents from high conflict homes.

Detailed description

Adolescents from homes with interparental conflict will be randomly assigned to Learning to BREATHE Plus (the standard group program designed to increase mindfulness, plus a multi-method adaptive intervention that will be comprised of an ecological momentary intervention and online library of mindfulness practices) or to a health and wellness active control condition to determine feasibility, acceptability, and potential effectiveness of Learning to BREATHE Plus.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLearning to BREATHE PlusActivities include psycho-education about stress and emotion regulation, and practices of body scanning, non-aerobic yoga, and meditation, which are designed to cultivate and provide opportunities to practice present-focused, non-judgmental attention.
BEHAVIORALHealth and wellnessThe Health Education Wellness Program (modeled after Hey Durham) (Bravender, 2005) will provide didactic information on substance use, nutrition/body image, stress management, exercise, and signs of depression/suicide.

Timeline

Start date
2021-02-17
Primary completion
2022-11-10
Completion
2022-11-10
First posted
2019-03-11
Last updated
2023-06-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03869749. Inclusion in this directory is not an endorsement.